Cryptococcal Meningitis: Clinical Trials

2 trials for Cryptococcal Meningitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2
Phase 32Recruiting 2

Follow Cryptococcal Meningitis: new trials by email Literature Review of Cryptococcal Meningitis trials Research Report on Cryptococcal Meningitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)
Standard of care, Oteseconazole - antifungal therapy 1, Turletricin injection - antifungal therapy 2 - Hiv, Cryptococcal Meningitis
Phase 2 / Phase 3RecruitingDavid Boulware20002025-05-282026-07-27
Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia
Single dose liposomal Amphotericin and Fluconazole, Fluconazole - Cryptococcal Meningitis
Phase 2 / Phase 3RecruitingMakerere University3562019-06-202026-04-28

Narrower conditions

Meningitis, Cryptococcal (2)  ·  Acquired Immunodeficiency Syndrome (1)

Broader conditions

Bacterial Infections and Mycoses (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Fungal Infections (2)  ·  Central Nervous System Infections (2)  ·  Cryptococcosis (2)  ·  Infections (2)  ·  Meningitis (2)  ·  Meningitis, Fungal (2)  ·  Mycoses (2)  ·  Nervous System Diseases (2)  ·  Neuroinflammatory Diseases (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)

Interventions

Amphotericin B (1)  ·  Fluconazole (1)  ·  Standard of Care (1)  ·  liposomal amphotericin B (1)

Sponsors

David Boulware (1)  ·  Makerere University (1)

Countries

Uganda (2)

Top investigators

David B Meya, MBChB, MMed, PhD (1)  ·  David R Boulware, MD, MPH (1)

Results publications

PMID 39044381